Category Archives: Avastin

Featured Stories

Johnson & Johnson Facing More Metal-on-Metal Hip Implant Woes, as DePuy Pinnacle Complaints Rise

Having already spent around $3 billion on its DePuy Orthopaedics ASR hip implant recall, Johnson & Johnson is facing another potential debacle involving a metal-on-metal version of its Pinnacle Hip Replacement System. According to a report from Reuters, Johnson & Johnson and its DePuy unit already face some 1,600 metal-on-metal ...

Actos Whistleblower Lawsuit Questions Avandia Researcher's Financial Ties to Takeda

A prominent researcher has been implicated in an alleged cover-up of Actos side effects, according to a report from TheHeart.org. An Actos whistleblower lawsuit unsealed earlier this year has alleged financial connections between the Cleveland Clinic’s Dr Steven Nissen and the maker of Actos “should be considered when analyzing Actos’s ...

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

West Virginia Man Claims Metal-on-Metal DePuy Pinnacle Hip Replacement Led to Pain, Elevated Cobalt Levels

A West Virginia man fitted with a metal-on-metal version of DePuy Orthopaedics’ Pinnacle Hip Implant System has filed suit against the company and its parent, Johnson & Johnson, alleging the device caused him to suffer pain and elevated cobalt levels. The Plaintiff is being represented by the national law ...

Read More

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth.

Read More

FDA Warning for Bone Graft Products in Patients Under 18

FDA Safety Warning for Bone Graft Products in Patients Under 18

FDA issued safety alerts to patients, parents & guardians, bone graft devices w/recombinant proteins or synthetic peptides not to be the first treatment for 18 & under.

Read More

Image Source: wisegeek.com

Trial over Ethicon Transvaginal Mesh Begins in California

Pelvic mesh devices have become the subject of safety concerns in recent years amidst reports that they can cause serious, sometimes permanent injuries.

Read More

Cancer Groups Call for E-cigarettes Regulation/Research

Two Leading Cancer Groups Issue Call for Regulation of E-cigarettes and Research on Health Risks

In a joint statement, the American Society of Clinical Oncology and the American Association for Cancer Research have called on the federal government to move quickly to regulate e-cigarettes and increase research on their health effects. These leading research and treatment organizations asked the Food and Drug Administration (FDA) to make ...

Read More

Hip Replacement, Knee Implant Patients with Diabetes, Other Health Problems May Face Difficult Recoveries

Patients receiving hip replacement devices or knee implants may face a more complicated recovery if they are obese, or suffer from diabetes or other health woes. According to a new study published online in the journal Anesthesiology, at least 3% of all total hip or knee replacement patients will ...

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed. According to press release issued Jan. 7, a resolution was introduced by Council Member Margaret Chin, Council Speaker Melissa Mark-Viverito and Council Members Paul Vallone and I. ...

Read More

Avastin Tied to High Blood Pressure, Gastrointestinal Bleeding Risks

avastin_blood_pressure_link

The cancer medication, Avastin (bevacizumab), has been tied to increased episodes of hypertension (high blood pressure) and gastrointestinal bleeding, according to a recently published article. The article appears online in the August 27, 2013 issue of the journal Clinical Drug … Continue reading

Posted in Avastin, Pharmaceuticals |

U.K. Citizen Sentenced in U.S. for Distributing Fake Avastin

us_citizen_arrested_selling_fake_avastin

A British citizen was just sentenced by United States authorities to prison time and a substantial fine over distributing bogus prescription drugs. The U.S. attorney’s office for the Eastern District of Missouri said that Richard J. Taylor of Warwickshire, England … Continue reading

Posted in Avastin, Pharmaceuticals |

Study: Avastin Offers No Advantage in Treatment of Brain Cancer

news_inferno_blogimage_Avastin_Brain_Cancer

Cancer drug, Avastin (bevacizumab), did not extend survival in patients with deadly brain masses, according to an emerging study. The Roche Holding AG medication offered no advantage as a first-line therapy against glioblastoma, a type of brain cancer, according to … Continue reading

Posted in Avastin, Legal News, Pharmaceuticals |

Cancer Drug, Avastin, Recalled Over Life-Threatening Infections

Avastin_Recalled_Cancer_Drug_Infection

Hoffmann-La Roche Limited has recalled Avastin (bevacizumab) following cases of necrotizing fasciitis, some fatal, reported in patients receiving the chemotherapy drug in both clinical trials and in the post-marketing setting. Necrotizing fasciitis is a rare, life-threatening infection of the soft … Continue reading

Posted in Avastin, Pharmaceuticals |

Cancer Drug, Avastin, Used Off-Label for Macular Degeneration, Recalled for Serious Eye Infections

The U.S. Food and Drug Administration (FDA) just announced that Clinical Specialties recalled 79 lots of Avastin (bevacizumab) unit dose syringes, over the potential for serious eye infection. The recalled Avastin has, or could potentially, lead to an infection in … Continue reading

Posted in Avastin, Pharmaceuticals, Product Recalls, Recalled Drugs |

FDA warns of counterfeit Avastin distributed by New York company

Federal health officials have issued another warning about counterfeits of the cancer drug Avastin that have been distributed in the U.S. This is the third warning issued by the Food and Drug Administration in the last year about the presence … Continue reading

Posted in Avastin, Consumer Fraud, Defective Medical Devices, Defective Products, Health Concerns, Pharmaceuticals | Tagged , |

FDA Finds More Counterfeit Cancer Drugs

The U.S. Food & Drug Administration (FDA) has found more counterfeit cancer drugs, it said. A prior international counterfeit Avastin investigation spanned from California, to Turkey, to Egypt. This new scam also involves a batch of counterfeit Avastin—a cancer medication … Continue reading

Posted in Avastin, Pharmaceuticals |

Counterfeit Avastin Highlights Weak Drug Protections

The recent counterfeit Avastin debacle highlights the issue with weak drug protections. The international investigation spanned from California, to Turkey, to Egypt. Avastin is a cancer medication manufactured by Roche. Many are concerned that as drug counterfeiters fine-tune their practices, … Continue reading

Posted in Avastin, Pharmaceuticals |

Egypt May Have Been Source For Counterfeit Avastin

Egypt may have been the source for counterfeit Avastin recently discovered at U.S. health care facilities and prompting the maker of the cancer drug to warn doctors and patients about the bogus medicines. Now, authorities are trying to determine if … Continue reading

Posted in Avastin, Pharmaceuticals |

Counterfeit Avastin Discovered At U.S. Health Facilities

Counterfeit Avastin was just discovered at U.S. health care facilities, prompting the maker of the cancer drug to warn doctors and patients about the bogus medications. According to Roche’s Genentech, the fake Avastin does not contain the key ingredient in … Continue reading

Posted in Avastin, Pharmaceuticals |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.